Tower Research Capital (TRC)’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $388K | Sell |
10,035
-9,362
| -48% | -$328K | 0.01% | 1204 |
|
|
2026
Q1 | $747K | Buy |
19,397
+11,834
| +156% | +$437K | 0.02% | 672 |
|
|
2025
Q4 | $269K | Buy |
7,563
+182
| +2% | +$5.12K | 0.01% | 1224 |
|
|
2025
Q3 | $106K | Sell |
7,381
-10,424
| -59% | -$123K | ﹤0.01% | 1941 |
|
|
2025
Q2 | $128K | Buy |
17,805
+12,613
| +243% | +$69.9K | ﹤0.01% | 2175 |
|
|
2025
Q1 | $31.1K | Sell |
5,192
-6,975
| -57% | -$54.7K | ﹤0.01% | 2578 |
|
|
2024
Q4 | $94.9K | Buy |
12,167
+11,562
| +1,911% | +$115K | ﹤0.01% | 2170 |
|
|
2024
Q3 | $6.53K | Sell |
605
-21,759
| -97% | -$212K | ﹤0.01% | 4136 |
|
|
2024
Q2 | $189K | Buy |
22,364
+19,720
| +746% | +$150K | ﹤0.01% | 2119 |
|
|
2024
Q1 | $17.8K | Sell |
2,644
-37,212
| -93% | -$230K | ﹤0.01% | 3099 |
|
|
2023
Q4 | $234K | Buy |
39,856
+36,939
| +1,266% | +$283K | ﹤0.01% | 1966 |
|
|
2023
Q3 | $28.4K | Buy |
2,917
+979
| +51% | +$11.6K | ﹤0.01% | 3063 |
|
|
2023
Q2 | $22.9K | Sell |
1,938
-1,092
| -36% | -$12.5K | ﹤0.01% | 3263 |
|
|
2023
Q1 | $33K | Sell |
3,030
-88
| -3% | -$1.13K | ﹤0.01% | 2887 |
|
|
2022
Q4 | $36K | Sell |
3,118
-231
| -7% | -$2.86K | ﹤0.01% | 2580 |
|
|
2022
Q3 | $50K | Buy |
3,349
+323
| +11% | +$4.43K | ﹤0.01% | 3150 |
|
|
2022
Q2 | $27K | Buy |
3,026
+603
| +25% | +$4.12K | ﹤0.01% | 3468 |
|
|
2022
Q1 | $18K | Buy |
2,423
+981
| +68% | +$6.83K | ﹤0.01% | 3617 |
|
|
2021
Q4 | $13K | Sell |
1,442
-1,377
| -49% | -$12K | ﹤0.01% | 4157 |
|
|
2021
Q3 | $24K | Sell |
2,819
-5,345
| -65% | -$41K | ﹤0.01% | 3553 |
|
|
2021
Q2 | $66K | Buy |
+8,164
| New | +$69K | ﹤0.01% | 2781 |
|
|
2020
Q4 | – | Sell |
-2,267
| Closed | -$21K | – | 5151 |
|
|
2020
Q3 | $21K | Sell |
2,267
-1,830
| -45% | -$19.1K | ﹤0.01% | 3846 |
|
|
2020
Q2 | $8K | Buy |
+4,097
| New | +$7.6K | ﹤0.01% | 4095 |
|
|
2019
Q4 | – | Sell |
-5,401
| Closed | -$31K | – | 3645 |
|
|
2019
Q3 | $31K | Buy |
+5,401
| New | +$43.9K | ﹤0.01% | 2163 |
|
|
2019
Q2 | – | Sell |
-972
| Closed | -$17K | – | 3754 |
|
|
2019
Q1 | $17K | Sell |
972
-61
| -6% | -$1.04K | ﹤0.01% | 2355 |
|
|
2018
Q4 | $18K | Buy |
1,033
+922
| +831% | +$27.3K | ﹤0.01% | 2011 |
|
|
2018
Q3 | $5K | Buy |
111
+40
| +56% | +$2.26K | ﹤0.01% | 3104 |
|
|
2018
Q2 | $4K | Buy |
+71
| New | +$3.41K | ﹤0.01% | 3116 |
|
Other funds holding COGT
Tower Research Capital (TRC)'s COGT Position: Q2 2026 in Review
Tower Research Capital (TRC) reduced its Cogent Biosciences (COGT) stake by 48% in Q2 2026, selling an estimated $328K and leaving 10,035 shares worth $388K. The position accounts for 0.01% of the portfolio, ranked #1204.
Tower Research Capital (TRC) first reported a position in COGT in Q2 2018 and has held it in 28 quarters since. The position peaked at $747K in Q1 2026. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.
- Tower Research Capital (TRC) held 10,035 shares of Cogent Biosciences worth $388K as of Q2 2026.
- Tower Research Capital (TRC) sold 9,362 Cogent Biosciences shares in Q2 2026, an estimated $328K.
- Cogent Biosciences made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1204 holding.
- Tower Research Capital (TRC) first reported a position in Cogent Biosciences in Q2 2018 and has held it in 28 quarters since.
- Tower Research Capital (TRC)'s Cogent Biosciences position peaked at $747K in Q1 2026.
- 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.